Global Next Generation Sequencers Market: Overview
Next generation sequencing (NGS) has opened a whole new avenue for researchers to study biological systems at a level never before possible, reaching new heights with its unprecedented speed, throughput, and scalability. Beyond the limited capacity of traditional DNA sequencing technologies, next generation sequencers provide answers to critical genomic research questions and is now becoming an everyday research tool. The next generation sequencing technology helps in rapid sequencing and produces thousands to millions of sequences in a single run. Owing to this escalated usefulness, the global next generation sequencers market is projected for a healthy CAGR during the forecast period of 2016 to 2024.
This report on next generation sequencers is a thorough study of the global market, which has been developed to help current and future players to make more informed choices for their business. The report not only analyzes all the factors that are expected to influence the market and presents a figurative future estimation, it also profiles some of the key companies currently operation in global next generation sequencers market for their market share, product portfolio, and other strategic developments.
Based on technology, the market can be segmented into single-molecule real-time sequencing (SMRT), pyrosequencing, ion semiconductor sequencing, sequencing by ligation, sequencing by synthesis, and chain termination. Since all these technologies are proprietary and protected through intellectual property rights, new players must develop independent technology to make a market over the market. By application, the market can be segmented into oncology, reproductive health, immune system monitoring, agrigenomics and forensics, consumer genomics, and clinical investigations including infectious disease, inherited diseases, idiopathic diseases, and non-communicable diseases.
Global Next Generation Sequencers Market: Trends and Opportunities
Growing automation in the pre-sequencing protocols is expected to drive the global next generation sequencers market during the forecast period. Utilization of new platforms for the development of personalized medicine by genetic level medical analysis is another prominent factor expected to escalate the demand for NGS over the forecast period. The report also expects the increased number of research and development projects in the field of metabolomics, transcriptomics, and proteomics to reflect on global next generation sequencers market. Some of the other factors driving the market are increasing adoption among researchers, academicians and customers, growing healthcare expenditure for the development of effective diagnostic and therapeutic procedure for cancer, low cost DNA sequencing, and microarray technology by NGS.
Conversely, the lack of computational efficiency for data management, non-value based NGS reimbursement policy and regulation status, and challenges associated with NGS implementations are the factors that may hinder the growth rate during the forecast period.
Global Next Generation Sequencers Market: Region-wise Outlook
North America currently contributes to the maximum demand in next generation sequencers market and the demand is expected to sustain over the duration of forecast period, primarily from the developed economies of the U.S. and Canada, who have technologically advanced healthcare framework and high adoption rate of new technologies. Several prominent companies in this field are based out of the U.S., which also reflects on heavy investments on research and development in the country. Europe market for next generation sequencers is also formidable, as the majority of respondents for academic and clinical use are located in the U.K. and Germany. For instance, Illumina Inc. inaugurated its European headquarters in Cambridge in 2015, taking initiative to gain share of revenue generated through 10,000 genome project carried out in the country. Asia Pacific, though a smaller regional market as of now, is projected for most robust growth rate among all the regions, owing to improving healthcare infrastructure in the emerging economies of India and China.
Companies Mentioned in the Research Report
Some of the key companies currently operational in global next generation sequencers market are Pacific Biosciences, Illumina Inc., Beijing Genomics Institute, F Hoffman-La Roche, Oxford Nanopore Technologies Inc., GATC Biotech AG., Thermo Fisher Scientific, Agilent Technologies Inc., Biomatters Ltd., Helicos BioSciences, DNAStar Inc., Macrogen Inc., CLC Bio (Qiagen), and Knome Inc.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.